How to Find a Licensed Medical Device Distributor in the Philippines

The Philippines' medical device market is governed by FDA Philippines' Center for Device Regulation, Radiation Health and Research (CDRRHR) — and every importer and distributor must hold a valid License to Operate (LTO) as the precondition to importing any medical device. With 8,000+ LTO holders across a $900M market, identifying a distributor with the right LTO scope, CPR registration capability, and hospital network requires a structured approach that goes well beyond commercial introductions.

Philippines FDA and the CDRRHR Framework

Republic Act 9711 — the Food and Drug Administration Act of 2009— established FDA Philippines and granted it authority to regulate medical devices. The landmark Medical Devices Act of 2020 (RA 11223), enacted in March 2020, went further by creating a standalone regulatory framework for medical devices specifically, bringing the Philippines' system progressively into alignment with GHTF/IMDRF principles.

Within FDA Philippines, the CDRRHR (Center for Device Regulation, Radiation Health and Research) serves as the dedicated competent authority for medical devices. CDRRHR administers both the LTO (establishment licence) and the CPR (product registration) systems.

FDA Philippines uses a three-class risk system: Class I (low risk), Class II (moderate risk), and Class III (high risk). The LTO is the establishment-level licence required by all medical device importers and distributors, renewed annually. The CPR (Certificate of Product Registration) is the product-level registration for Class II and III devices, held by the local distributor or importer.

Step 1 — Verify the License to Operate

The LTO check is the mandatory first step. A distributor without an active, valid LTO cannot legally import or distribute medical devices in the Philippines — regardless of how commercially compelling they appear. Never proceed past the first meeting without completing this verification.

Search the FDA Philippines Online Unified Search Portal

Access uvrs.fda.gov.ph or contact CDRRHR directly. Search by establishment name and confirm: Active LTO status, licence type (Importer, Distributor, or both), and expiry date. Both Importer and Distributor LTO categories are relevant — confirm which licences your prospective partner holds.

Confirm LTO Scope Covers Your Device Class

An LTO is not a blanket licence. A Class I establishment may not have the regulatory infrastructure, technical staff, or compliance systems to handle Class III CPR applications. Confirm that your distributor's LTO scope and operational capability align with the risk class of your device.

Check FDA Philippines' Published Revocation and Suspension Orders

FDA Philippines publishes enforcement actions publicly. Before shortlisting any distributor, verify they have no recent adverse regulatory actions — no LTO revocations, suspension orders, or product recalls linked to their establishment. An adverse enforcement history is a serious disqualifying factor.

Step 2 — Understand Philippines' Class I–III Device System

The device class determines the registration pathway, technical documentation requirements, and realistic timeline to market. Selecting a distributor who is experienced with the specific class of your device is critical — the regulatory workload differs substantially between Class I notifications and full Class III CPR applications with clinical evidence.

For a deeper comparison of how device risk tiers map across the region, see our guide to medical device risk classification in Southeast Asia.

Step 3 — Evaluate Regulatory Capability

Holding an active LTO is necessary but not sufficient. Your distributor must have the regulatory affairs infrastructure to prepare and manage a CPR application for your specific device class. For Class II and III devices, the technical file requirements, response to Requests for Additional Information (RAIs), and post-market surveillance obligations are substantial. A distributor without genuine CPR submission experience will delay your market entry.

Request the Distributor's CPR Portfolio

Ask how many active Class II/III CPRs they currently hold. Request specific CPR numbers so you can independently verify them against the FDA Philippines UVRS portal. A distributor with a substantial, verifiable CPR portfolio in your device class is demonstrably capable. One without is a regulatory risk.

Ask Specifically About RA 11223 Submission Experience

The implementing rules under RA 11223 introduced new documentation requirements and post-market surveillance obligations. Distributors who have successfully navigated RA 11223 submissions — rather than operating only under the older FDA Act framework — are better positioned to handle the evolving regulatory environment efficiently.

Confirm a QP-Equivalent / Designated Technical Officer

FDA Philippines under RA 11223 requires that distributors have technical staff responsible for managing post-market surveillance and adverse event reporting. Confirm your prospective distributor has a named, qualified Technical Officer — and that this person is not shared across dozens of principals with no bandwidth for active engagement.

Step 4 — Assess Their Hospital and Government Channel

Regulatory clearance gets your product to market. Commercial capability determines whether it actually sells. The Philippines' hospital procurement landscape is divided between DOH-managed public hospitals, private hospital groups, and the PhilHealth reimbursement system — each requiring different distributor capabilities and relationships.

Step 5 — Conduct Due Diligence

Before signing a distribution agreement, complete structured due diligence that goes well beyond the basic LTO check. The Philippines' CPR system creates a long-term dependency on your distributor — the due diligence investment at this stage pays dividends throughout the relationship.

• Verify LTO (Importer + Distributor) via FDA UVRS portal — confirm Active status and annual renewal date
• Request full CPR portfolio for your device class — verify at least 3 CPR numbers against the UVRS portal
• Confirm the distributor has no current FDA Philippines enforcement actions, recall orders, or LTO suspension notices
• Ask for 2 foreign principal references from current manufacturers — direct contact preferred, not written testimonials
• Verify GDP-compliant warehouse with adequate cold chain capability if required for your device type
• Review draft distribution and CPR agreement — specify CPR transfer process, who owns the technical file, and what happens on termination
• Confirm designated Technical Officer (QP equivalent) for adverse event reporting under RA 11223

Common Mistakes to Avoid

• Appointing a distributor with only Class I experience for Class II/III devices — the CPR application process requires significantly different technical documentation expertise that Class I-only distributors typically lack
• Not negotiating a CPR Transfer Clause — without it, an adversarial distributor can hold your registration indefinitely after contract termination, blocking your ability to appoint a new partner
• Overlooking PhilHealth registration as a commercial barrier — many hospital procurement channels require PhilHealth benefit package listing; confirm your distributor can navigate this process
• Assuming FDA Philippines timelines are reliable — Class II/III backlogs have consistently exceeded published targets. Budget 18–24 months for Class II and up to 24 months for Class III in your market entry plan
• Not planning for RA 11223 evolution — implementing rules are still being progressively issued; distributors unfamiliar with the transition may create compliance gaps that expose your products to regulatory action

Continue your research with our Vietnam MOH registration guide or compare approaches across markets in the Indonesia distributor guide.